Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.1 EUR | +1.32% |
|
-4.96% | -20.14% |
06-28 | Would you like some more inflation? | ![]() |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GENMAB A/S | Bio Therapeutic Drugs | +0.88% | -4.96% | -20.14% | -33.91% | - | 15.71B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- GMAB Stock
- GE91 Stock
- Charts Genmab A/S
- Comparison Chart